Brian M Lingerfelt, MD

Medical Oncology and Hematology Specialist located in Charleston, SC & Mt Pleasant, SC

About Dr. Lingerfelt

Brian M. Lingerfelt, MD earned his undergraduate degree in Chemistry from Furman University in Greenville, South Carolina. He graduated from Virginia Commonwealth University School of Medicine at the Medical College of Virginia Campus in Richmond, Virginia and continued his medical training with internship and residency in Internal Medicine at Virginia Commonwealth University Health System. He completed his fellowship in Hematology and Medical Oncology at the Emory University Winship Cancer Institute in Atlanta, Georgia. Dr. Lingerfelt performed extensive laboratory research at Furman University synthesizing anti-cancer drugs and at Virginia Commonwealth University Health System analyzing the effect of checkpoint kinase inhibitors in multiple myeloma cell lines. His clinical research at Emory University focused on the inflammatory response to tyrosine kinase inhibitors in kidney cancer. He has published in the Journal of Supportive Oncology, the Journal of Pharmaceutical and Biomedical Analysis, and Bioorganic and Medicinal Chemistry. He is a member of the American Medical Association, the American Society of Clinical Oncology, and the American Society of Hematology. Dr. Lingerfelt joined Charleston Hematology Oncology Associates, P.A., in 2012.

Read more
,  Office of Brian M Lingerfelt, MD

Brian M. Lingerfelt, MD earned his undergraduate degree in Chemistry from Furman University in Greenville, South Carolina. He graduated from Virginia Commonwealth University School of Medicine at the Medical College of Virginia Campus in Richmond, Virginia and continued his medical training with internship and residency in Internal Medicine at Virginia Commonwealth University Health System. He completed his fellowship in Hematology and Medical Oncology at the Emory University Winship Cancer Institute in Atlanta, Georgia. Dr. Lingerfelt performed extensive laboratory research at Furman University synthesizing anti-cancer drugs and at Virginia Commonwealth University Health System analyzing the effect of checkpoint kinase inhibitors in multiple myeloma cell lines. His clinical research at Emory University focused on the inflammatory response to tyrosine kinase inhibitors in kidney cancer. He has published in the Journal of Supportive Oncology, the Journal of Pharmaceutical and Biomedical Analysis, and Bioorganic and Medicinal Chemistry. He is a member of the American Medical Association, the American Society of Clinical Oncology, and the American Society of Hematology. Dr. Lingerfelt joined Charleston Hematology Oncology Associates, P.A., in 2012.


Read less

Insurance Providers

If you have any questions about your insurance participation please call our office.

Absolute Total Care
Aetna
Blue Cross Blue Shield
Cigna
Coventry
Humana
Medcost
Medicaid
Medicare Advantage
Molina Healthcare
Tricare
United Health Care